PetVivo Holdings, Inc. announced the appointment of Mike Eldred as the Company’s Commercialization and Operations Advisor and Executive Director. This strategic hire leverages Mr. Eldred’s 30 years of executive experience in animal health and the veterinary industry.
Mr. Eldred previously served as President of North American Operations for Dechra Pharmaceutical for 20 years, where he built the subsidiary to over $450 million in annual revenue. His proven record of business achievement is expected to significantly drive and accelerate the adoption of Spryng.
In his new role, Mr. Eldred will focus on ramping up PetVivo's product development and sales efforts, bringing valuable expertise to the company's commercialization strategy. This appointment is anticipated to be a key resource for achieving PetVivo's business goals in the competitive animal health market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.